Description

Ala-Ala-Asn-PAB TFA is a peptide cleavable ADC linker for antibody-drug conjugates (ADCs)[1].-4°C (Powder, sealed storage, away from moisture)–Cancer-programmed cell death–C19H26F3N5O7—-[1]Cheng X, et al. MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity. Mol Cancer Ther. 2018 Dec;17(12):2665-2675.—-493.43–90.06–OCC1=CC=C(NC([C@H](CC(N)=O)NC([C@H](C)NC([C@@H](N)C)=O)=O)=O)C=C1.O=C(O)C(F)(F)F–Cancer–10 mM in DMSO–ADC Linker—-Antibody-drug Conjugate/ADC Related–Peptides